newsThe FDA has granted fast track designation for Pfizer and…
15 June 2017 | By Niamh Marriott (European Pharmaceutical Review)
The FDA has granted fast track designation for Pfizer and Eli Lilly’s tanezumab for the treatment of chronic pain in patients with osteoarthritis...